FIUSEX:NMF-FIUSEX (USD)

MUTUAL FUND | Others |

Last Closing

USD 10.1045

Change

+0.02 (+0.19)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

ETFs Containing FIUSEX

IPAY Amplify ETF Trust 4.24 % 0.75 %

N/A

USD 0.34B
ZFIN:CA 3.53 % 0.00 %

N/A

N/A
EBUY:F Lyxor Index Fund - Lyxor .. 2.94 % 0.00 %

N/A

N/A
KNOW Direxion All Cap Insider .. 1.72 % 0.67 %

N/A

N/A
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
DGIT:LSE iShares Digitalisation UC.. 0.00 % 0.00 %

N/A

N/A
SBUY:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
XAXD:LSE Xtrackers - MSCI AC Asia .. 0.00 % 0.00 %

N/A

N/A
XAXJ:LSE Xtrackers MSCI AC Asia ex.. 0.00 % 0.00 %

N/A

N/A
EMWE:F BNP Paribas Easy - MSCI W.. 0.00 % 0.00 %

N/A

N/A
DRUP:XETRA Amundi MSCI Disruptive Te.. 0.00 % 0.00 %

N/A

N/A
EKUS:XETRA BNP Paribas Easy MSCI USA.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike